Anti-tumor Activity of Bufalin by Inhibiting c-MET Mediated MEK/ERK and PI3K/AKT Signaling Pathways in Gallbladder Cancer
In conclusion, Bufalin can be used as a new promising anticancer drug for gallbladder cancer patients who are resistant to traditional chemotherapy.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Liqiang Qian, Haoyuan Su, Gang Wang, Bin Li, Genhai Shen, Quangen Gao Tags: Research Paper Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Gallbladder Cancer | Stem Cell Therapy | Stem Cells | Study